166 results on '"Rose, B.S."'
Search Results
2. Psychiatric or Drug Hospitalizations in Older Cancer Survivors on Long-Term Opioids
3. Health System Practices and Perspectives of Social Risk Screening in Oncology
4. Prostate Cancer Screening Uptake in Transgender Females
5. Increasing Use of Conservative Management of Low-Risk Prostate Cancer in the Veterans Affairs System from 2012 to 2021
6. FORMULA-509: A Multicenter Randomized Trial of Post-Operative Salvage Radiotherapy (SRT) and 6 Months of GnRH Agonist with Either Bicalutamide or Abiraterone Acetate/Prednisone (AAP) and Apalutamide (Apa) Post-Radical Prostatectomy (RP)
7. Association between National Area Deprivation Index Rank on Disease Characteristics in Prostate Cancer
8. Association of Transgender or Gender Non-Binary Identity on Disease Characteristics and Survival Outcomes in Prostate Cancer
9. Predictors of Low-Value PSA Screening in Elderly Men
10. Racial Disparities in Palliative Radiation for African American Men with Metastatic Prostate Cancer
11. Prognostic Value of the Intermediate Risk Feature in Men with Favorable Intermediate Risk Prostate Cancer: Implications for Active Surveillance
12. Association of Prostate-Specific Antigen Screening Rates and Subsequent Metastatic Prostate Cancer Incidence in a National Healthcare System
13. Examining the Impact of Direct Patient Care for Medical Physicists: A Randomized Prospective Phase III Trial
14. Functional Outcomes after Radiation Therapy or Radical Prostatectomy with Postoperative Radiation Therapy for High-Risk Prostate Cancer
15. Racial Disparities in Patient Perspectives on Shared Decision Making in Prostate Cancer Screening Following 2018 Guideline Changes
16. Patterns of Failure After Definitive Chemoradiation for Muscle-Invasive Bladder Cancer
17. Defining Racial Disparities Across the Prostate Cancer Disease Continuum in an Equal Access-to-Care Setting Within the Nation's Largest Healthcare Network
18. Evaluating Clinical Trends and Benefits of Low-Dose CT in Lung Cancer Patients
19. Factors Associated With Treatment Discontinuation in Patients With Muscle-Invasive Bladder Cancer Undergoing Chemoradiation
20. Treatment of older patients with immune checkpoint inhibitors in routine clinical care as compared to inclusion in pivotal registration trials
21. Vedolizumab Tissue Concentration Correlates to Mucosal Inflammation and Objective Treatment Response in Inflammatory Bowel Disease
22. The influence of body composition on the systemic exposure of paclitaxel in esophageal cancer patients
23. Outcomes for Men with Intermediate-risk Prostate Cancer on Active Surveillance
24. Rates of New Opioid Prescription during Curative Intent Cancer Treatment by Race and Socioeconomic Status
25. Is There An Association Between Use Of Androgen Deprivation Therapy And Acute Kidney Injury In Prostate Cancer Patients Treated With Definitive Radiotherapy?
26. Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in Muscle-Invasive Bladder Cancer
27. Association of PSA Velocity with Disease Progression and Metastases in Men with Low Risk Prostate Cancer on Active Surveillance
28. Stroke and Thromboembolic Events in Men with Prostate Cancer Treated with Definitive Radiation Therapy with or without Androgen Deprivation Therapy
29. Pathologic Upgrading and Mortality in Men with Low-Risk Prostate Cancer Treated with Radical Prostatectomy
30. Characterization and Prediction of Opioid Use in Head and Neck Cancer Patients Undergoing Local Therapy
31. Combined Androgen Blockade in Men with Intermediate and High Risk Localized Prostate Cancer Treated with Definitive Radiation Therapy
32. Validity of Using Cancer Registry Data in Comparative Effectiveness Research Involving Radiation Therapy
33. Prognostic Impact of Neutrophil-to-Lymphocyte Ratio in Solid Cancers
34. Racial Equity among African-American and Non-Hispanic White Men Diagnosed with Prostate Cancer in the Veterans Affairs Healthcare System
35. Impact of Prediagnosis Statins on Prostate Cancer-Specific Mortality in the Veterans Affairs Healthcare System
36. Association between Tobacco Smoking and Prostate Cancer-Specific Mortality in the Veterans Affairs Healthcare System
37. Impact of Older Age on the Exposure of Paclitaxel: a Population Pharmacokinetic Study
38. Does Older Age Lead to Higher Risk for Neutropenia in Patients Treated with Paclitaxel?
39. Age-Associated Hematological Toxicity in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Docetaxel in Clinical Practice
40. Exposure to Docetaxel in the Elderly Patient Population: a Population Pharmacokinetic Study
41. Age-Associated Hematological Toxicity in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Docetaxel in Clinical Practice
42. ADT and Dementia in Veterans with Prostate Cancer Treated with Definitive Radiation Therapy
43. Definitive Local Therapy and Survival in Clinically Node-Positive Prostate Cancer
44. Association Between Finasteride use Prior to Prostate Cancer Diagnosis and Prostate Cancer-Specific Survival
45. Automated Text Mining of Prostate Pathology Reports Extracted from an Electronic Medical System, using a Rule-Based Approach
46. The Veterans Affairs Disparity Paradox: Racial Disparities Among a Cohort of American Military Veterans with Prostate Cancer
47. Influence of Age on Treatment Outcomes in Intermediate or High-Risk Prostate Cancer Treated with Androgen Deprivation Therapy and Radiation Therapy
48. Therapeutic drug monitoring of small molecule kinase inhibitors in oncology in a real-world cohort study: does age matter?
49. Therapeutic drug monitoring of small molecule kinase inhibitors in oncology in a real-world cohort study : does age matter?
50. Therapeutic drug monitoring of small molecule kinase inhibitors in oncology in a real-world cohort study: does age matter?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.